Conmed Corp is a leading global medical technology company. Its business model revolves around offering a wide range of surgical products and services to healthcare professionals worldwide. The company specializes in the development, manufacturing, and marketing of innovative surgical devices and equipment. With a focus on minimally invasive procedures, Conmed Corp aims to enhance patient outcomes and reduce healthcare costs. By providing solutions for areas such as electrosurgery, endosurgery, and orthopedic surgery, Conmed Corp continues to drive advancements in the medical field. This commitment to delivering high-quality products and advancing medical technologies solidifies its position as a trusted industry leader.

Conmed Corp is primarily active in the medical devices industry.

The main competitors of Conmed Corp in the market include Medtronic, Johnson & Johnson, Stryker Corporation, and Smith & Nephew.

Conmed Corp. is a renowned medical technology company with a rich history and strong background. Founded in 1970, Conmed Corp. has been dedicated to providing innovative surgical solutions and equipment to healthcare professionals worldwide. With its headquarters in Utica, New York, the company has grown to become a leading player in the field of minimally invasive procedures. Conmed Corp. offers a wide range of products, including surgical instruments, endoscopic technologies, and electrosurgical systems, designed to enhance patient outcomes and streamline healthcare processes. With a focus on research and development, Conmed Corp. continues to shape the future of surgical advancements and improve the standard of patient care.

Conmed Corp has achieved several significant milestones throughout its history. The company has successfully established itself as a leading global medical technology provider, specializing in surgical devices and equipment. Conmed Corp has expanded its product portfolio and enhanced its research and development efforts to cater to a wide range of medical specialties. The company has also received numerous accolades and recognition for its innovative solutions and commitment to improving patient outcomes. With its relentless dedication to advancing clinical education and training, Conmed Corp has become a trusted name in the healthcare industry, ensuring enhanced surgical techniques and superior patient care.

Conmed Corp is primarily present in various countries and regions across the globe. The company has a significant presence in the United States, where its headquarters is located. Additionally, Conmed Corp has established a strong market presence in Europe, especially in countries like Germany, France, and the United Kingdom. The company also operates in Asian markets, including China and Japan, and has a growing presence in emerging markets such as India and Brazil. Furthermore, Conmed Corp has a global distribution network, allowing its products and services to reach healthcare facilities worldwide.

Conmed Corp represents a commitment to delivering innovative medical solutions. With a strong corporate philosophy centered around the core values of integrity, quality, and customer focus, the company aims to improve patient outcomes. Conmed Corp is dedicated to maintaining high ethical standards, fostering a culture of continuous improvement, and promoting teamwork and collaboration. By combining cutting-edge technology with a patient-centric approach, Conmed Corp strives to provide healthcare professionals with advanced tools and services that address the evolving needs of the medical community.

Analysts currently set an average price target of 45.08 USD for the Conmed stock (median: 43.86 USD), implying +17.2 % versus the latest price. The consensus is based on 12 analyst ratings.

Conmed Analyst Price Targets 2026

11 analysts currently rate the Conmed stock: 0 recommend buying, 8 holding and 3 selling. For 2026, analysts expect Conmed to generate revenue of 1.39 B USD and earnings per share of 4.44 USD.

Conmed Analyst Price Targets 2026

Converted at the current exchange rate, the Conmed share trades at 33.74 EUR (38.48 USD).

The Conmed share (CNMD) is listed on 5 stock exchanges, including: NYSE (CNMD), Frankfurt (EC8.F), München (EC8.MU), Düsseldorf (EC8.DU), SIX (Zürich) (EC8.SW).

Conmed Corporation is a multinational provider of medical devices and instruments used in orthopedics, gastroenterology, endoscopy, laparoscopy, and other medical fields. The company is headquartered in Utica, New York, and operates in more than 30 countries. Conmed has a diverse business segment that focuses on three main categories: Surgical Instruments, Endoscopy, and Electrosurgery. These three divisions offer various products tailored to the specific needs of surgeons and other medical professionals. The Surgical Instruments division includes a wide range of products such as scissors, forceps, needle holders, scalpels, retractors, and other specialized surgical instruments. These instruments are used in a variety of surgical procedures to ensure precision and safety. Endoscopy is an increasingly important field of study in medicine. Here, Conmed offers a range of products such as endoscopes, capsule endoscopes, endoscopic ultrasound probes, and endoscopy accessories. Endoscopes allow doctors to examine internal organs and tissues, reducing the costs and risks associated with traditional surgery. The Electrosurgery division includes products such as generators, active electrodes, monopolar instruments, bipolar instruments, and accessories. Electrosurgery is used in many surgical procedures to cut, coagulate, or remove tissue. Conmed's products enable surgeons to quickly and effectively remove tissue without causing damage to healthy tissue. Conmed's products are used by a variety of medical professionals in various medical fields. The company also provides excellent customer support, ensuring that surgeons and medical professionals can receive assistance at any time. Conmed has introduced the following products on the market: - Hall Zimmer Surgical PowerTools: The system offers electrically powered surgical hand drills, saws, grinders, and other surgical instruments for orthopedics. - Edge Bipolar Clamping System: This is a bipolar instrument system with a universal cable that can be used in many different surgical procedures. - PRO360 Digital Laparoscopy System: A complete endoscopic device system that provides clear, high-resolution imaging for laparoscopy. - EndoRotor Medical Endoscopy Cleaner: This device allows endoscopy systems to be cleaned, disinfected, and sterilized in a simpler and more effective way. Conmed has a robust service and support system aimed at maintaining customer trust and loyalty. Furthermore, Conmed continuously strives to acquire new knowledge and improve its technology to provide surgeons and other medical professionals with the best instruments and products to enhance their success rate and patient outcomes. Overall, Conmed has a first-class business model that helps medical professionals make their work more effective and safer. The company puts its expertise and technology at the service of the healthcare community and is committed to the safety of its customers and their patients. Answer: Conmed Corporation is a multinational provider of medical devices and instruments used in various medical fields such as orthopedics, gastroenterology, and endoscopy. The company focuses on three main categories: Surgical Instruments, Endoscopy, and Electrosurgery. They offer a wide range of products tailored to the specific needs of surgeons and other medical professionals. Conmed aims to provide reliable customer support and continuously improve their technology to enhance the success and safety of medical procedures.

The expected revenue of Conmed is 1.39 B USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Conmed is 138.39 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Conmed is currently 8.66. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Conmed stock.

The price-to-sales ratio (P/S) of Conmed is currently 0.86. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Conmed stock.

The Eulerpool Quality Score for Conmed is 5/10.

The ISIN of Conmed is US2074101013. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Conmed is 886793. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Conmed is CNMD. The ticker symbol is used to trade Conmed shares on the stock exchange.

Over the past 12 months, Conmed paid a dividend of 0.60 USD . This corresponds to a dividend yield of about 1.56 %. For the coming 12 months, Conmed is expected to pay a dividend of 0.80 USD.

The current dividend yield of Conmed is 1.56 %.

Conmed pays a dividend, distributed in the months of , , , .

Conmed paid dividends every year for the past 14 years.

For the upcoming 12 months, dividends amounting to 0.80 USD are expected. This corresponds to a dividend yield of 2.08 %.

Conmed is assigned to the 'Health' sector.

To receive the latest dividend of Conmed from amounting to 0.2 USD, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

In the year 2025, Conmed distributed 0.8 USD as dividends.

The dividends of Conmed are distributed in USD.